Related Experiment Videos

Apoptosis in SLE--too little or too much?

K B Elkon1

  • 1Specialized Center of Research (SCOR) in SLE, Hospital for Special Surgery, Cornell University Medical College, New York, NY 10021.

Insights

Immune cells undergo programmed cell death unless activated. Defects in the Fas/APO-1 pathway, crucial for immune tolerance, can lead to lupus-like diseases in mice.

Area of Science:

  • Immunology
  • Cell Biology
  • Autoimmunity

Background:

  • Immune system cells are programmed for death unless activated by immune responses.
  • Soluble and surface signals can induce active cell death pathways.
  • These pathways are critical for maintaining self-tolerance.

Purpose of the Study:

  • To investigate the role of Fas/APO-1 pathway in immune tolerance.
  • To understand the implications of Fas/APO-1 defects in autoimmune diseases like lupus.

Main Methods:

  • Analysis of mouse models with spontaneous mutations in the Fas/APO-1 receptor or its ligand.
  • Examination of immune cell persistence in relation to Fas/APO-1 function.
  • Comparison of Fas/APO-1 pathway in humans with Systemic Lupus Erythematosus (SLE).

Main Results:

  • Mutations in Fas/APO-1 or its ligand cause lupus-like diseases in mice.
  • Fas/APO-1 signaling defects explain the persistence of self-reactive cells in lpr mice.
  • Fas/APO-1 receptor expression is normal in human SLE, suggesting other pathway defects.

Conclusions:

  • The Fas/APO-1 pathway is vital for immune tolerance, and its defects contribute to autoimmunity.
  • Further research is needed to identify other molecular defects in the Fas/APO-1 pathway or cell death/survival pathways in SLE.

Related Concept Videos